Daniel Navarro
About
In The Last Decade
Daniel Navarro
17 papers receiving 672 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 295
- Oncology 282
- Pulmonary and Respiratory Medicine 238
- Cellular and Molecular Neuroscience 125
- Cancer Research 95
Countries citing papers authored by Daniel Navarro
This map shows the geographic impact of Daniel Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Navarro more than expected).
Fields of papers citing papers by Daniel Navarro
This network shows the impact of papers produced by Daniel Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Navarro. The network helps show where Daniel Navarro may publish in the future.
Co-authorship network of co-authors of Daniel Navarro
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Navarro. A scholar is included among the top collaborators of Daniel Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Navarro. Daniel Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 34 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | Hepatitis B, C y en coinfección con VIH en un Banco de Sangre en Corrientes, Argentina | 0 |
| 7 | 28 | |
| 8 | 93 | |
| 9 | 35 | |
| 10 | Pulmonary-Hepatic vascular Disorders (PHD) R. Rodriguez-Roisin*, M.J. Krowka # , Ph. Herve ´ } , M.B. Fallon z , on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee | 60 |
| 11 | 56 | |
| 12 | Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase. | 5 |
| 13 | Synergistic activation of the androgen receptor by bombesin and low-dose androgen. | 26 |
| 14 | Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. | 49 |
| 15 | Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. | 69 |
| 16 | 61 | |
| 17 | 124 | |
| 18 | Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation. | 35 |
| 19 | Indium 111 imaging in appendicitis. | 2 |
| 20 | Autoradiographic comparison of thallium-201 diethyldithiocarbamate, isopropyliodoamphetamine and iodoantipyrine as cerebral blood flow tracers. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.